DOCEON contains docetaxel, an anti-cancer agent used in chemotherapy for treating various cancers, including breast cancer, lung cancer, and other types of tumors. Docetaxel works by interfering with cell division, preventing tumor cells from growing and causing their destruction. The drug is used as part of combination therapy regimens for cancer treatment.
The product is used for:
Breast cancer
Non-small cell lung cancer
Head and neck cancer
Ovarian cancer
Treatment of other oncological diseases as prescribed by a doctor
DOCEON is administered intravenously, typically once every 3 weeks. The dosage and duration of treatment are determined by the doctor based on the patient's condition and type of cancer. The drug is infused slowly via an IV drip, and the dosage may be adjusted depending on the patient’s response and side effects. The administration process and dosage should be monitored by a healthcare professional.
Contraindications:
Hypersensitivity to docetaxel or other components of the product
Severe liver disease
Bone marrow dysfunction
Pregnancy and breastfeeding (under medical supervision)
Severe infections
Side Effects:
Nausea, vomiting
Loss of appetite
Headache, dizziness
Fatigue, weakness
Hair loss (alopecia)
Decreased white blood cell count (leukopenia)
Fever (rarely)
